‘Time to invest in genomics’ in poorer countries – WHO
SciDev.net
; 2022.
Article
in English
| ProQuest Central | ID: covidwho-1998629
ABSTRACT
Speed read Genomics has been crucial in COVID-19 response, driving research But many poor countries lack access to the technology First WHO Science Council report makes recommendations to address barriers The World Health Organization (WHO) has issued an urgent call to accelerate access to genomics, especially in resource-poor countries, in a report that examines technology gaps and opportunities. Genomics is the branch of science that uses methods from biochemistry, genetics, and molecular biology to understand and use biological information in DNA and RNA to benefit medicine and public health — but the technology can also be used in agricultural research. While genomics technology is driving some of the most ground-breaking research in medical science, including COVID-19 vaccine research and development, its full potential is yet to be realised globally, especially in low- and middle-income countries (LMICs), according to the WHO Science Council’s inaugural report.
Medical Sciences; Laboratories; Pathogens; Public health; Medical research; Vaccines; Science; Agricultural research; Genomes; Research & development--R&D; Driving ability; Genomics; Molecular biology; COVID-19; Medical science; Infrastructure; Councils; Technology; Pandemics; Genetics; Deoxyribonucleic acid--DNA; Surveillance; COVID-19 vaccines; Coronaviruses; Tedros Adhanom Ghebreyesus
Search on Google
Collection:
Databases of international organizations
Database:
ProQuest Central
Language:
English
Journal:
SciDev.net
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS